Conclusion

We appreciate the Subcommittee's consideration of our concerns and its recognition of the benefits of cloning technology in improving and saving people's lives. Again, we urge the Subcommittee to "first, do no harm" to vital biomedical research. We look forward to working with the Subcommittee and Congress during the consideration of this issue.